Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
12.81
-0.44 (-3.32%)
At close: Apr 28, 2026, 4:00 PM EDT
13.06
+0.25 (1.95%)
After-hours: Apr 28, 2026, 5:48 PM EDT
Cullinan Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 775 | 611 | 709 | 436 | 483 | 674 | |
| Market Cap Growth | 74.81% | -13.79% | 62.69% | -9.73% | -28.36% | - | |
| Enterprise Value | 401 | 280 | 134 | -25 | -88 | 355 | |
| Last Close Price | 12.82 | 10.35 | 12.18 | 10.19 | 10.55 | 15.43 | |
| PE Ratio | - | - | - | - | 4.34 | - | |
| PS Ratio | - | - | - | - | - | 35.58 | |
| PB Ratio | 1.89 | 1.50 | 1.20 | 0.96 | 0.90 | 1.59 | |
| P/TBV Ratio | 1.90 | 1.50 | 1.20 | 0.96 | 0.90 | 1.59 | |
| EV/Sales Ratio | - | - | - | - | - | 18.75 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | - | |
| Net Debt / Equity Ratio | -0.92 | -0.92 | -0.67 | -1.02 | -0.86 | -0.68 | |
| Net Debt / EBITDA Ratio | 1.56 | 1.56 | 2.02 | 2.44 | 3.50 | 4.28 | |
| Net Debt / FCF Ratio | 2.13 | 2.13 | 2.73 | 3.45 | 3.62 | 6.69 | |
| Asset Turnover | - | - | - | - | - | 0.06 | |
| Quick Ratio | 10.09 | 10.09 | 13.12 | 16.60 | 20.77 | 24.73 | |
| Current Ratio | 10.25 | 10.25 | 13.53 | 17.07 | 21.09 | 25.25 | |
| Return on Equity (ROE) | -44.02% | -44.02% | -32.10% | -31.37% | 22.74% | -21.57% | |
| Return on Assets (ROA) | -28.23% | -28.23% | -22.26% | -22.80% | -16.55% | -13.03% | |
| Return on Invested Capital (ROIC) | -314.90% | -212.89% | -214.14% | -601.95% | -89.53% | -108.71% | |
| Return on Capital Employed (ROCE) | -58.80% | -58.80% | -33.30% | -41.80% | -24.50% | -16.00% | |
| Earnings Yield | -28.34% | -35.96% | -23.60% | -35.13% | 23.03% | -9.73% | |
| FCF Yield | -22.66% | -28.75% | -20.49% | -30.85% | -26.46% | -6.44% | |
| Buyback Yield / Dilution | -9.82% | -9.82% | -29.41% | 10.91% | -8.27% | -116.61% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.